Literature DB >> 7398530

Timolol eye drops: bradycardia or tachycardia?

F E Ros, C L Dake.   

Abstract

26 eyes of 14 patients--8 with primary open angle glaucoma, 6 glaucoma suspects--were treated for at least 6 months with either twice daily timolol 0.25% in both eyes or twice daily timolol 0.50% in one eye. None of the patients received concomitant local or oral drugs. Special attention was paid to tachyphylaxis and to blood pressure and pulse rate. We could detect a slight although not significant tendency to tachyphylaxis (1-2 mm Hg) after 1 week of timolol treatment. It takes at least 1-2 weeks to reach the initial I.O.P. level after withdrawal of timolol therapy. Blood pressure did not change significantly. The pulse rate showed a slight although not significant tendency to decrease (a few beats/minute), but we detected a reflex tachycardia (10 beats/minute) after withdrawal of timolol therapy which was very significant. This rebound phenomenon has not been referred to in the literature. It seems reasonable to conclude that one should take care in treating glaucoma patients with concomitant arrhythmias with timolol eye drops.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398530     DOI: 10.1007/bf00141455

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  16 in total

1.  Myocardial infarction after propranolol withdrawal.

Authors:  R G Diaz; J Somberg; E Freeman; B Levitt
Journal:  Am Heart J       Date:  1974-08       Impact factor: 4.749

2.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.

Authors:  R R Miller; H G Olson; E A Amsterdam; D T Mason
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

3.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

4.  Timolol, dose response and duration of action.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

5.  Effect of topical atenolol on intraocular pressure.

Authors:  K Wettrell; M Pandolfi
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

6.  Atenolol eye drops in glaucoma: a double-masked, controlled study.

Authors:  C I Phillips; S M Gore; M J Macdonald; P M Cullen
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

7.  Timolol. A new drug for management of chronic simple glaucoma.

Authors:  R L Radius; G R Diamond; I P Pollack; M E Langham
Journal:  Arch Ophthalmol       Date:  1978-06

8.  Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma.

Authors:  W P Boger; C A Puliafito; R F Steinert; D P Langston
Journal:  Ophthalmology       Date:  1978-03       Impact factor: 12.079

9.  A comparison of the effects of timolol and epinephrine on intraocular pressure.

Authors:  A P Moss; R Ritch; N A Hargett; A N Kohn; H Smith; S M Podos
Journal:  Am J Ophthalmol       Date:  1978-10       Impact factor: 5.258

10.  Absence of an effect of timolol on the pupil.

Authors:  S H Johnson; R F Brubaker; J C Trautman
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-09       Impact factor: 4.799

View more
  2 in total

1.  Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients.

Authors:  M Francesca Cordeiro; Ivan Goldberg; Rhett Schiffman; Paula Bernstein; Marina Bejanian
Journal:  Clin Ophthalmol       Date:  2015-08-31

2.  Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon.

Authors:  Jie Shen; Marina Bejanian
Journal:  Clin Ophthalmol       Date:  2016-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.